Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 8/20 | 0.58 |
| ▸ | CYP4A11 | Q02928 | 8/20 | 0.58 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.33 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.32 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22399923 | 0.94 | CYP4F2 (0.59) | CYP4F2CYP4A11TBXAS1CYP2C19GPR84 | |
| SCHEMBL10257161 | 0.94 | CYP4F2 (0.53) | CYP4F2CYP4A11TBXAS1CYP2C19GPR84 | |
| SCHEMBL17099452 | 0.94 | CYP4F2 (0.53) | CYP4F2CYP4A11TBXAS1CYP2C19GPR84 | |
| SCHEMBL28119855 | 0.92 | CYP4F2 (0.58) | CYP4F2CYP4A11TBXAS1CYP2C19GPR84 | |
| SCHEMBL798439 | 0.91 | TBXAS1 (0.50) | CYP4F2CYP4A11TBXAS1CYP2C19CPB2 | |
| SCHEMBL11226563 | 0.91 | CYP4F2 (0.50) | CYP4F2CYP4A11TBXAS1CYP2C19GPR84 | |
| SCHEMBL798202 | 0.87 | TBXAS1 (0.54) | CYP4F2CYP4A11TBXAS1CYP2C19CPB2 | |
| SCHEMBL9182194 | 0.87 | TBXAS1 (0.54) | CYP4F2CYP4A11TBXAS1CYP2C19CPB2 | |
| SCHEMBL797992 | 0.87 | TBXAS1 (0.45) | CYP4F2CYP4A11TBXAS1CYP2C19CPB2 | |
| SCHEMBL798204 | 0.87 | TBXAS1 (0.45) | CYP4F2CYP4A11TBXAS1CYP2C19CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5859239-A | Mercaptoalkanoylamino and acylmercaptoalkanoylamino benzoxazepines and benzothiazepines | E. R. SQUIBB & SONS, INC. (US) | 1999-01-12 | — | — | US | disclosed |
| US-5856476-A | Processes for preparing azepiones useful as intermediates in the preparation of inhibitors of angiotensin converting enzyme and neutral endopeptidase | E. R. SQUIBBS & SONS, INC. (US) | 1999-01-05 | — | — | US | disclosed |
| US-5856477-A | HYPOTENSIVE AGENTS; CONGESTIVE HEART FAILURE | E. R. SQUIBB & SONS, INC. (US) | 1999-01-05 | — | — | US | disclosed |
| US-5723602-A | ANGIOTENSIN CONVERTING ENZYME AND ENDOPEPTIDASE INHIBITORS, CARDIOVASCULAR DISORDERS | E. R. SQUIBB & SONS, INC. (US) | 1998-03-03 | — | — | US | disclosed |
| US-5723457-A | COMPOUMDS FOR CARDIOVASCULAR DISORDERS AND INHIBITORS OF ANGIOTENSIN CONVERTING ENZYMES | E. R. SQUIBB & SONS, INC. (US) | 1998-03-03 | — | — | US | disclosed |
| US-5654294-A | CARDIOVASCULAR DISORDERS | BRISTOL-MYERS SQUIBB (US) | 1997-08-05 | — | — | US | disclosed |
| US-5646276-A | ANGIOTENSIN CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE INHIBITORS; CARDIOVASCULAR DISORDERS | BRISTOL-MYERS SQUIBB CO. (US) | 1997-07-08 | — | — | US | disclosed |
| US-5552397-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1996-09-03 | — | — | US | disclosed |